MoonLake Immunotherapeutics OverviewMoonLake Immunotherapeutics Net Income
Profitability analysis for MLTX.
Quarterly Net Income
-$69.71M
↓ 73.17% YoY
As of Mar 2026
Annual Net Income (TTM)
-$257.82M
↓ 76.12% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...